Olson Charles V 4

What Happened

• Charles V. Olson, a director of Edesa Biotech, was granted 19,000 restricted share units (RSUs) on 2026-05-27. The grant price reported is $0.00, so no cash was exchanged; reported value at grant is $0 in the filing. This is an award/grant transaction, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-27 (Form 4 filed 2026-05-29).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 19,000 RSUs.
• Price per share/unit: $0.00; total reported cash value: $0.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: RSUs issued under the Issuer's 2019 Equity Incentive Compensation Plan vest in equal proportions over 12 months, commencing on the grant date.
• Timeliness: Form 4 was filed two days after the grant date (within the typical 2-business-day reporting window), so it appears timely.

Context

• RSUs are a form of equity compensation that convert to shares if/when they vest; they are not an immediate cash investment by the insider and do not represent a sale. Such grants are common for compensation and retention and should be viewed as awards rather than direct market endorsements.